
IP6K2 is a client for HSP90 and a target for cancer therapeutics development
Author(s) -
David S. Shames,
John D. Minna
Publication year - 2008
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.0711993105
Subject(s) - cancer , medicine